STOCK COMMENTS / EPS CHANGESAlcoa ( AA) estimates, target reduced at JP Morgan. AA estimates were cut through 2012, JP Morgan said. Aluminum prices remain weak and the company continues to face higher costs. Overweight rating and new $13 price target. Alcoa numbers adjusted at UBS. Shares of AA now seen reaching $10.25, according to UBS. Estimates lowered on lower LME prices and ongoing European weakness. Neutral rating. Acuity Brands ( AYI) numbers increased at JMP. AYI estimates were raised through 2012, JMP Securities said. Higher pricing should drive margin expansion. Outperform rating and new $64 price target. Acuity Brands numbers raised at Jefferies. Shares of AYI now seen reaching AYI, Jefferies said. Estimates also raised on solid first quarter results. Hold rating. Celgene ( CELG) target raised at Citigroup. CELG price target increased to $80, according to Citigroup. Company released positive guidance. Buy rating. Celgene numbers raised at Jefferies. Shares of CELG now seen reaching $78, Jefferies said. Estimates also raised on bullish 2012 guidance. Buy rating. Capital One ( COF) added to Top Pick List at FBR. COF was placed on the Top Pick list, FBR Capital Markets said. Recent acquisitions should boost future earnings. Cirrus Logic ( CRUS) estimates raised at Oppenheimer through 2012, Oppenheimer said. Positive guidance update. Perform rating. CVS Caremark ( CVS) numbers raised at Credit Suisse. Shares of CVS now seen reaching $48, according to Credit Suisse. Estimates also increased, as the company has several potential earnings tailwinds. Outperform rating. Juniper ( JNPR) estimates lowered at Oppenheimer through 2012, Oppenheimer said. Disappointing negative pre-announcement. Perform rating. Juniper estimates, target lowered at Goldman. JNPR estimates were cut through 2013, Goldman Sachs said. Carriers are spending less and the company appears to be losing market share in the router business. Neutral rating and new $19 price target. Juniper Networks estimates lowered at UBS. JNPR estimates lowered through 2012, UBS said. Weaker than expected preliminary 4Q results. Neutral rating. Juniper estimates lowered at Jefferies. JNPR estimates lowered through 2012, Jefferies said. Negative pre-announcement. Buy rating. Southwest ( LUV) estimates lowered at UBS. LUV estimates lowered through 2012 on December revenue, UBS said. Maintain $9.50 price target and Neutral rating. Macy's ( M) estimates, target boosted at Credit Suisse. Shares of M now seen reaching $36, according to Credit Suisse. Estimates also upped, given strong sales momentum. Outperform rating. Regeneron Pharmaceuticals ( REGN) price target raised at Citigroup. REGN price target increased to $68 on strong initial Eylea sales, Citigroup said. Neutral rating. Schnitzer Steel ( SCHN) numbers cut at Goldman. Shares of SCHN now seen reaching $47, according to Goldman Sachs. Estimates also reduced, given margin compression. Neutral rating. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.